Status:
COMPLETED
Role of Mosapride in Patients With Gastroesophageal Reflux Disease
Lead Sponsor:
Lotung Poh-Ai Hospital
Collaborating Sponsors:
Tomorrow Medical Foundation
Conditions:
Gastroesophageal Reflux Disease
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
Gastroesophageal reflux disease (GERD) is a very common disease in the Western World. In Taiwan, this disease is increasing gradually because the investigators' eating style is closing to Western worl...
Detailed Description
This is a randomized, double-blind, cross-over study. FSSG is obtained at the beginning, one month and two months of the study. This study plans to enroll 100 patients with symptoms of GERD (acid reg...
Eligibility Criteria
Inclusion
- Aged between 18 and 90 years old
- Outpatients
- Characteristic GERD symptoms: acid regurgitation, heart burn, or belching
- Erosive esophagitis on upper digestive endoscopy, based on Los Angeles classification
Exclusion
- History of allergy to lansoprazole or mosapride
- Pregnant or lactating women
- Uremia
- Decompensated liver disease
- Age under 18 and over 90 years-old
- Lack of informed consent
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT00729339
Start Date
June 1 2008
End Date
May 1 2009
Last Update
May 13 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lotung Poh-Ai Hospital
Lotung Town, Ilan County, Taiwan, 265